BU
BUB.AU Bubs Australia Ltd
- Market cap
- AUD 69.8M
- P/E
- -
- P/B
- 1.79x
- ROE
- -11.8%
- Dividend yield
- -
- Fundamental score
- 1.1/5
Ratios use the latest price and the fiscal year ending Jun 2026.
Is BUB.AU undervalued?
Graham numberThe Graham number of Bubs Australia Ltd cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Bubs Australia Ltd fundamental analysis
5 of 21 checks passedROE 0/2
Low return on equity (-11.8%), below 10%.
ROA 0/1
Return on assets (-6.4%) is below the industry median (-3.9%).
Profit Consistency 0/2
Not profitable for at least 3 consecutive years.
Earnings Growth 5Y 1/1
Earnings per share grew over the past 5 years.
Earnings Acceleration 0/1
Not enough positive earnings history to compare last year's growth with the 5-year average.
Earnings Growth vs Industry 0/1
Last year's EPS growth (-183.3%) is below the industry median (-27.6%).
Revenue Growth 2/2
Revenue grew 23.0% a year over the past 3 years.
Short-term Liquidity 1/1
Current assets cover short-term liabilities.
Long-term Liabilities 1/1
Current assets cover long-term liabilities.
Debt to Equity 1/2
Moderate debt to equity (40.8%), up to 100%.
Debt Trend 0/1
Debt to equity has risen over the past 5 years.
Cash Runway 0/2
Cash covers 0.6 years of the current cash burn.
PE vs Market 0/1
PE is negative or not available.
PE vs Industry 0/1
PE is negative or not available.
PBV 0/1
Price to book (1.8x) is above the industry median (1.3x).
Graham Number 0/1
Graham number needs positive earnings and book value.
PEG 0/1
PEG needs positive PE and positive 5-year earnings growth.
Dividend Yield 0/2
No dividend paid in the last reported year.
Dividend Stability 0/2
Dividends were not paid steadily for the past 5 years.
Dividend Growth 0/1
Dividends paid did not grow over the past 5 years.
Payout Ratio 0/1
No dividend, or no profit to pay it from.
Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score
Bubs Australia Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Bubs Australia Ltd
Bubs Australia Limited, together with its subsidiaries, manufactures and sell infant and adult chilled and powdered goat dairy products in Australia, China, the United States, and internationally. The company provides goat and cow milk infant formulas, goat milk powder products for adults, and fresh dairy products. It also offers organic baby food, cereals, snacks, and chilled goat milk. In addition, the company holds IP and trademarks. It sells its products under the Bubs a…
Full company profileBubs Australia Ltd financial statements
Bubs Australia Ltd annual financial statements (AUD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 3.93M | 16.9M | 43.9M | 54.6M | 39.3M | 89.3M | 60.1M | 79.7M | 103M | 112M |
| Gross Profit | 856K | 1.67M | 8.61M | 6.64M | -10.7M | 26.2M | -11.7M | 38.7M | 49.1M | 43.2M |
| Operating Income | -3.37M | -9.42M | -29.6M | -15.1M | -31.7M | -10.5M | -70.3M | -20.6M | 4.51M | -4.34M |
| EBITDA | -4.95M | -66.0M | -33.5M | -10.8M | -73.0M | -7.45M | -104M | -19.1M | 5.49M | -2.77M |
| Net Income | -5.06M | -64.7M | -35.5M | -7.77M | -74.7M | -11.4M | -108M | -21.0M | 5.54M | -4.62M |
| EPS | -0.02 | -0.20 | -0.08 | -0.01 | -0.12 | -0.02 | -0.15 | -0.03 | 0.01 | -0.01 |
| Balance Sheet | ||||||||||
| Total Assets | 9.00M | 89.0M | 155M | 162M | 106M | 126M | 65.6M | 66.8M | 57.2M | 72.2M |
| Total Liabilities | 1.48M | 16.5M | 48.9M | 29.6M | 18.9M | 37.7M | 23.9M | 29.9M | 14.7M | 33.2M |
| Shareholders' Equity | 7.52M | 72.5M | 106M | 132M | 87.0M | 88.2M | 41.7M | 36.9M | 42.5M | 39.0M |
| Cash & Short-term Investments | 5.31M | 38.6M | 23.7M | 26.0M | 27.9M | 16.3M | 26.1M | 17.5M | 17.4M | 9.41M |
| Total Debt | - | 2.00M | 2.00M | 4.59M | 4.16M | 4.92M | 4.41M | 7.00M | 968K | 15.9M |
| Cash Flow | ||||||||||
| Operating Cash Flow | -2.10M | -12.8M | -17.2M | -21.9M | -22.6M | -9.37M | -46.5M | -26.3M | 6.13M | -15.1M |
| Capital Expenditure | 54.8K | 29.0K | 82.7K | 219K | 610K | 557K | 247K | 190K | 83.0K | 506K |
| Free Cash Flow | -2.15M | -12.8M | -17.2M | -22.1M | -23.2M | -9.93M | -46.7M | -26.5M | 6.05M | -15.6M |
| Ratios | ||||||||||
| ROE | -67.2% | -89.2% | -33.6% | -5.9% | -85.9% | -12.9% | -260.0% | -56.9% | 13.1% | -11.8% |
| ROA | -56.2% | -72.7% | -23.0% | -4.8% | -70.6% | -9.0% | -165.2% | -31.4% | 9.7% | -6.4% |
| Net Profit Margin | -128.7% | -382.5% | -80.9% | -14.2% | -190.1% | -12.7% | -180.3% | -26.3% | 5.4% | -4.1% |
| Debt to Equity | - | 0.03x | 0.02x | 0.03x | 0.05x | 0.06x | 0.11x | 0.19x | 0.02x | 0.41x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Bubs Australia Ltd dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2026 | - | - | - |
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | AUD 58.5M | 0.08 | - |
| 2022 | - | - | - |
| 2021 | AUD 28.6M | 0.05 | - |
| 2020 | AUD 32.0M | 0.06 | - |
| 2019 | AUD 24.7M | 0.05 | - |
| 2018 | - | - | - |
| 2017 | AUD 311K | 0.00 | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 3:50 on Dec 12, 2016.
Who owns Bubs Australia Ltd
- Insiders 21.17%
- Institutions 0.68%
- Public & others 78.15%
- Shares outstanding 895M
- Free float 682M
Bubs Australia Ltd company profile
- Company name
- Bubs Australia Ltd
- Ticker
- BUB.AU
- ISIN
- AU000000BUB7
- Exchange
- Australian Securities Exchange
- Sector
- Consumer Defensive
- Industry
- Food Products
- Employees
- 118
- Fiscal year end
- June
- Address
- 23-29 Nina Link, Dandenong, VIC, Australia, 3175
- Phone
- 1800 2827 2878
- Website
- bubsaustralia.com
About Bubs Australia Ltd
Bubs Australia Limited, together with its subsidiaries, manufactures and sell infant and adult chilled and powdered goat dairy products in Australia, China, the United States, and internationally. The company provides goat and cow milk infant formulas, goat milk powder products for adults, and fresh dairy products. It also offers organic baby food, cereals, snacks, and chilled goat milk. In addition, the company holds IP and trademarks. It sells its products under the Bubs and Caprilac brands. The company exports its products. Bubs Australia Limited was founded in 2005 and is based in Dandenong, Australia.
Bubs Australia Ltd management
3- Mr. Joe CooteMD, CEO & Executive Director
- Mr. Richard PaineChief Operating Officer
- Mr. Chris RoweChief Financial Officer